Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Status:
Completed
Trial end date:
2014-02-13
Target enrollment:
Participant gender:
Summary
This study will compare the safety and efficacy of the 700 ug dexamethasone intravitreal
implant with ranibizumab 0.5 mg intravitreal injections in patients with diabetic macular
edema (DME).